Targeting Epac2 and GluA3-containing AMPARs: a novel therapeutic strategy for Alzheimer's disease.
Saved in:
| Title: | Targeting Epac2 and GluA3-containing AMPARs: a novel therapeutic strategy for Alzheimer's disease. |
|---|---|
| Authors: | Zhang T; Department of Molecular Pharmacology, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands (Zhang T, Schmidt M).; School of Pharmacy, Tianjin Medical University, Tianjin, China (Zhang T)., Schmidt M; Department of Molecular Pharmacology, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands (Zhang T, Schmidt M). |
| Source: | Neural regeneration research [Neural Regen Res] 2025 Nov 01; Vol. 20 (11), pp. 3223-3224. Date of Electronic Publication: 2024 Oct 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wolters Kluwer Health, Medknow Country of Publication: India NLM ID: 101316351 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1673-5374 (Print) Linking ISSN: 16735374 NLM ISO Abbreviation: Neural Regen Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1673-5374 |
|---|---|
| DOI: | 10.4103/NRR.NRR-D-24-00751 |
